{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:50:51Z","timestamp":1785840651445,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ratchadapisek Somphot Fund, Chulalongkorn University"},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A650231"],"award-info":[{"award-number":["N42A650231"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00894-025-06441-5","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T09:42:15Z","timestamp":1753782135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting SARS-CoV-2 main protease: a pharmacophore and molecular modeling approach"],"prefix":"10.1007","volume":"31","author":[{"given":"Nitchakan","family":"Darai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyatida","family":"Pojtanadithee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamonpan","family":"Sanachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolschann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyada","family":"Rungrotmongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"6441_CR1","unstructured":"World Health Organization (n.d.)\u00a0https:\/\/data.who.int\/dashboards\/covid19\/cases . Accessed 5 Dec 2024"},{"issue":"10223","key":"6441_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"issue":"3","key":"6441_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","volume":"63","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, Zhang Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C, Liu L (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63(3):364\u2013374. https:\/\/doi.org\/10.1007\/s11427-020-1643-8","journal-title":"Sci China Life Sci"},{"issue":"4","key":"6441_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92(4):418\u2013423. https:\/\/doi.org\/10.1002\/jmv.25681","journal-title":"J Med Virol"},{"key":"6441_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ejmech.2017.05.045","volume":"137","author":"L Wang","year":"2017","unstructured":"Wang L, Bao B-B, Song G-Q, Chen C, Zhang X-M, Lu W, Wang Z, Cai Y, Li S, Fu S, Song F-H, Yang H, Wang J-G (2017) Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study. Eur J Med Chem 137:450\u2013461. https:\/\/doi.org\/10.1016\/j.ejmech.2017.05.045","journal-title":"Eur J Med Chem"},{"issue":"30","key":"6441_CR6","doi-asserted-by":"publisher","first-page":"8744","DOI":"10.1021\/bi0621415","volume":"46","author":"DH Goetz","year":"2007","unstructured":"Goetz DH, Choe Y, Hansell E, Chen YT, McDowell M, Jonsson CB, Roush WR, McKerrow J, Craik CS (2007) Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus. Biochemistry 46(30):8744\u20138752. https:\/\/doi.org\/10.1021\/bi0621415","journal-title":"Biochemistry"},{"issue":"6497","key":"6441_CR7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.abb4489","volume":"368","author":"W Dai","year":"2020","unstructured":"Dai W, Zhang B, Jiang X-M, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang L-K, Xu Y, Yang H, Liu H (2020) Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 368(6497):1331\u20131335. https:\/\/doi.org\/10.1126\/science.abb4489","journal-title":"Science"},{"issue":"7811","key":"6441_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K, Liu F, Jiang R, Yang X, You T, Liu X, Yang X, Bai F, Liu H, Liu X, Guddat LW, Xu W, Xiao G, Qin C, Shi Z, Jiang H, Rao Z, Yang H (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582(7811):289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y","journal-title":"Nature"},{"issue":"1","key":"6441_CR9","doi-asserted-by":"publisher","first-page":"8620","DOI":"10.1038\/s41598-024-59292-0","volume":"14","author":"KM de Santiago-Silva","year":"2024","unstructured":"de Santiago-Silva KM, Camargo PG, Carvalho Constant LE, Costa SdS, Frensel GB, Allonso D, Nakazato G, Lima CHdS, Bispo MdLF (2024) Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro. Sci Rep 14(1):8620. https:\/\/doi.org\/10.1038\/s41598-024-59292-0","journal-title":"Sci Rep"},{"issue":"1","key":"6441_CR10","doi-asserted-by":"publisher","first-page":"20295","DOI":"10.1038\/s41598-021-99165-4","volume":"11","author":"CN Patel","year":"2021","unstructured":"Patel CN, Jani SP, Jaiswal DG, Kumar SP, Mangukia N, Parmar RM, Rawal RM, Pandya HA (2021) Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (Mpro) inhibitor using docking and molecular dynamics simulations. Sci Rep 11(1):20295. https:\/\/doi.org\/10.1038\/s41598-021-99165-4","journal-title":"Sci Rep"},{"issue":"6489","key":"6441_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","volume":"368","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R (2020) Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science 368(6489):409\u2013412. https:\/\/doi.org\/10.1126\/science.abb3405","journal-title":"Science"},{"issue":"1","key":"6441_CR12","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41598-024-51443-7","volume":"14","author":"HE Hashem","year":"2024","unstructured":"Hashem HE, Ahmad S, Kumer A, Bakri YE (2024) In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2. Sci Rep 14(1):1152. https:\/\/doi.org\/10.1038\/s41598-024-51443-7","journal-title":"Sci Rep"},{"issue":"1","key":"6441_CR13","doi-asserted-by":"publisher","first-page":"17106","DOI":"10.1038\/s41598-023-44476-x","volume":"13","author":"G Dakpa","year":"2023","unstructured":"Dakpa G, Kumar KJS, Nelen J, P\u00e9rez-S\u00e1nchez H, Wang S-Y (2023) Antcin-B, a phytosterol-like compound from Taiwanofungus camphoratus inhibits SARS-CoV-2 3-chymotrypsin-like protease (3CLPro) activity in silico and in vitro. Sci Rep 13(1):17106. https:\/\/doi.org\/10.1038\/s41598-023-44476-x","journal-title":"Sci Rep"},{"issue":"1","key":"6441_CR14","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1038\/s41598-022-06306-4","volume":"12","author":"GG Rossetti","year":"2022","unstructured":"Rossetti GG, Ossorio MA, Rempel S, Kratzel A, Dionellis VS, Barriot S, Tropia L, Gorgulla C, Arthanari H, Thiel V, Mohr P, Gamboni R, Halazonetis TD (2022) Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits. Sci Rep 12(1):2505. https:\/\/doi.org\/10.1038\/s41598-022-06306-4","journal-title":"Sci Rep"},{"issue":"16","key":"6441_CR15","doi-asserted-by":"publisher","first-page":"5244","DOI":"10.1021\/acs.jcim.3c00663","volume":"63","author":"P Pojtanadithee","year":"2023","unstructured":"Pojtanadithee P, Hengphasatporn K, Suroengrit A, Boonyasuppayakorn S, Wilasluck P, Deetanya P, Wangkanont K, Sukanadi IP, Chavasiri W, Wolschann P, Langer T, Shigeta Y, Maitarad P, Sanachai K, Rungrotmongkol T (2023) Identification of promising sulfonamide chalcones as inhibitors of SARS-CoV-2 3CLpro through structure-based virtual screening and experimental approaches. J Chem Inf Model 63(16):5244\u20135258. https:\/\/doi.org\/10.1021\/acs.jcim.3c00663","journal-title":"J Chem Inf Model"},{"key":"6441_CR16","doi-asserted-by":"publisher","first-page":"107125","DOI":"10.1016\/j.bpc.2023.107125","volume":"304","author":"P Pojtanadithee","year":"2024","unstructured":"Pojtanadithee P, Isswanich K, Buaban K, Chamni S, Wilasluck P, Deetanya P, Wangkanont K, Langer T, Wolschann P, Sanachai K, Rungrotmongkol T (2024) A combination of structure-based virtual screening and experimental strategies to identify the potency of caffeic acid ester derivatives as SARS-CoV-2 3CLpro inhibitor from an in-house database. Biophys Chem 304:107125. https:\/\/doi.org\/10.1016\/j.bpc.2023.107125","journal-title":"Biophys Chem"},{"issue":"4","key":"6441_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1021\/acscentsci.3c00054","volume":"9","author":"SA Chen","year":"2023","unstructured":"Chen SA, Arutyunova E, Lu J, Khan MB, Rut W, Zmudzinski M, Shahbaz S, Iyyathurai J, Moussa EW, Turner Z, Bai B, Lamer T, Nieman JA, Vederas JC, Julien O, Drag M, Elahi S, Young HS, Lemieux MJ (2023) SARS-CoV-2 M(pro) protease variants of concern display altered viral substrate and cell host target galectin-8 processing but retain sensitivity toward antivirals. ACS Cent Sci 9(4):696\u2013708. https:\/\/doi.org\/10.1021\/acscentsci.3c00054","journal-title":"ACS Cent Sci"},{"issue":"4","key":"6441_CR18","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1021\/acsinfecdis.3c00560","volume":"10","author":"JM Flynn","year":"2024","unstructured":"Flynn JM, Zvornicanin SN, Tsepal T, Shaqra AM, Kurt Yilmaz N, Jia W, Moquin S, Dovala D, Schiffer CA, Bolon DNA (2024) Contributions of hyperactive mutations in Mpro from SARS-CoV-2 to drug resistance. ACS Infectious Diseases 10(4):1174\u20131184. https:\/\/doi.org\/10.1021\/acsinfecdis.3c00560","journal-title":"ACS Infectious Diseases"},{"key":"6441_CR19","doi-asserted-by":"publisher","first-page":"105969","DOI":"10.1016\/j.antiviral.2024.105969","volume":"231","author":"S Rauch","year":"2024","unstructured":"Rauch S, Costacurta F, Sch\u00f6ppe H, Peng J-Y, Bante D, Erisoez EE, Sprenger B, He X, Moghadasi SA, Krismer L, Sauerwein A, Heberle A, Rabensteiner T, Wang D, Naschberger A, Dunzendorfer-Matt T, Kaserer T, von Laer D, Heilmann E (2024) Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe VSV-based system. Antiviral Res 231:105969. https:\/\/doi.org\/10.1016\/j.antiviral.2024.105969","journal-title":"Antiviral Res"},{"issue":"9","key":"6441_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s13238-021-00883-2","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Fang C, Zhang Q, Zhang R, Zhao X, Duan Y, Wang H, Zhu Y, Feng L, Zhao J, Shao M, Yang X, Zhang L, Peng C, Yang K, Ma D, Rao Z, Yang H (2022) Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332. Protein Cell 13(9):689\u2013693. https:\/\/doi.org\/10.1007\/s13238-021-00883-2","journal-title":"Protein Cell"},{"key":"6441_CR21","unstructured":"Biovia DS (2023) Discovery studio [software]. Version 2023 SP1. San Diego (CA): Dassault Syst\u00e8mes"},{"issue":"2","key":"6441_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander T, Freyss J, von Korff M, Rufener C (2015) DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model 55(2):460\u2013473. https:\/\/doi.org\/10.1021\/ci500588j","journal-title":"J Chem Inf Model"},{"issue":"1","key":"6441_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"issue":"1\u20133","key":"6441_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"6441_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/pro.3280","volume":"27","author":"E Jurrus","year":"2018","unstructured":"Jurrus E, Engel D, Star K, Monson K, Brandi J, Felberg LE, Brookes DH, Wilson L, Chen J, Liles K, Chun M, Li P, Gohara DW, Dolinsky T, Konecny R, Koes DR, Nielsen JE, Head-Gordon T, Geng W, Krasny R, Wei GW, Holst MJ, McCammon JA, Baker NA (2018) Improvements to the APBS biomolecular solvation software suite. Protein Sci 27(1):112\u2013128. https:\/\/doi.org\/10.1002\/pro.3280","journal-title":"Protein Sci"},{"issue":"1","key":"6441_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/cr950025u","volume":"97","author":"H-H Otto","year":"1997","unstructured":"Otto H-H, Schirmeister T (1997) Cysteine proteases and their inhibitors. Chem Rev 97(1):133\u2013172. https:\/\/doi.org\/10.1021\/cr950025u","journal-title":"Chem Rev"},{"key":"6441_CR27","unstructured":"Marvin 17.21.0 C: https:\/\/www.chemaxon.com Accessed 19 Aug 2022"},{"issue":"20","key":"6441_CR28","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","volume":"63","author":"DA Case","year":"2023","unstructured":"Case DA, Aktulga HM, Belfon K, Cerutti DS, Cisneros GA, Cruzeiro VWD, Forouzesh N, Giese TJ, G\u00f6tz AW, Gohlke H, Izadi S, Kasavajhala K, Kaymak MC, King E, Kurtzman T, Lee T-S, Li P, Liu J, Luchko T, Luo R, Manathunga M, Machado MR, Nguyen HM, O\u2019Hearn KA, Onufriev AV, Pan F, Pantano S, Qi R, Rahnamoun A, Risheh A, Schott-Verdugo S, Shajan A, Swails J, Wang J, Wei H, Wu X, Wu Y, Zhang S, Zhao S, Zhu Q, Cheatham TE III, Roe DR, Roitberg A, Simmerling C, York DM, Nagan MC, Merz KM Jr (2023) AmberTools. J Chem Inf Model 63(20):6183\u20136191. https:\/\/doi.org\/10.1021\/acs.jcim.3c01153","journal-title":"J Chem Inf Model"},{"issue":"1","key":"6441_CR29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian C, Kasavajhala K, Belfon KAA, Raguette L, Huang H, Migues AN, Bickel J, Wang Y, Pincay J, Wu Q, Simmerling C (2020) ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput 16(1):528\u2013552. https:\/\/doi.org\/10.1021\/acs.jctc.9b00591","journal-title":"J Chem Theory Comput"},{"key":"6441_CR30","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N log (N) method for Ewald sums in large systems. J Chem Phys 98:10089\u201310089","journal-title":"J Chem Phys"},{"issue":"21","key":"6441_CR31","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1021\/acs.jpcb.7b11734","volume":"122","author":"GA Ross","year":"2018","unstructured":"Ross GA, Rustenburg AS, Grinaway PB, Fass J, Chodera JD (2018) Biomolecular simulations under realistic macroscopic salt conditions. J Phys Chem B 122(21):5466\u20135486. https:\/\/doi.org\/10.1021\/acs.jpcb.7b11734","journal-title":"J Phys Chem B"},{"issue":"1","key":"6441_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1021\/ct400626b","volume":"10","author":"JS Hub","year":"2014","unstructured":"Hub JS, de Groot BL, Grubm\u00fcller H, Groenhof G (2014) Quantifying artifacts in Ewald simulations of inhomogeneous systems with a net charge. J Chem Theory Comput 10(1):381\u2013390. https:\/\/doi.org\/10.1021\/ct400626b","journal-title":"J Chem Theory Comput"},{"issue":"43","key":"6441_CR33","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L (2001) Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A 105(43):9954\u20139960. https:\/\/doi.org\/10.1021\/jp003020w","journal-title":"J Phys Chem A"},{"issue":"5","key":"6441_CR34","doi-asserted-by":"publisher","DOI":"10.1063\/5.0040966","volume":"154","author":"AC Simmonett","year":"2021","unstructured":"Simmonett AC, Brooks BR (2021) A compression strategy for particle mesh Ewald theory. J Chem Phys 154(5):054112. https:\/\/doi.org\/10.1063\/5.0040966","journal-title":"J Chem Phys"},{"issue":"9","key":"6441_CR35","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1021\/ci2000242","volume":"51","author":"T Sulea","year":"2011","unstructured":"Sulea T, Cui Q, Purisima EO (2011) Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 2. Benchmark in the CSAR-2010 scoring exercise. J Chem Inf Model 51(9):2066\u20132081. https:\/\/doi.org\/10.1021\/ci2000242","journal-title":"J Chem Inf Model"},{"issue":"10","key":"6441_CR36","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1021\/ci200191m","volume":"51","author":"MA Lill","year":"2011","unstructured":"Lill MA, Thompson JJ (2011) Solvent interaction energy calculations on molecular dynamics trajectories: increasing the efficiency using systematic frame selection. J Chem Inf Model 51(10):2680\u20132689. https:\/\/doi.org\/10.1021\/ci200191m","journal-title":"J Chem Inf Model"},{"issue":"1","key":"6441_CR37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1021\/ci600406v","volume":"47","author":"M Na\u00efm","year":"2007","unstructured":"Na\u00efm M, Bhat S, Rankin KN, Dennis S, Chowdhury SF, Siddiqi I, Drabik P, Sulea T, Bayly CI, Jakalian A, Purisima EO (2007) Solvated interaction energy (SIE) for scoring protein\u2212ligand binding affinities. 1. Exploring the parameter space. J Chem Inf Modelg 47(1):122\u2013133. https:\/\/doi.org\/10.1021\/ci600406v","journal-title":"J Chem Inf Modelg"},{"issue":"1","key":"6441_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"G Wolber","year":"2005","unstructured":"Wolber G, Langer T (2005) LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 45(1):160\u2013169. https:\/\/doi.org\/10.1021\/ci049885e","journal-title":"J Chem Inf Model"},{"key":"6441_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jbiotec.2017.07.028","volume":"261","author":"A Fillbrunn","year":"2017","unstructured":"Fillbrunn A, Dietz C, Pfeuffer J, Rahn R, Landrum GA, Berthold MR (2017) KNIME for reproducible cross-domain analysis of life science data. J Biotechnol 261:149\u2013156. https:\/\/doi.org\/10.1016\/j.jbiotec.2017.07.028","journal-title":"J Biotechnol"},{"issue":"11","key":"6441_CR40","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15 \u2013 ligand discovery for everyone. J Chem Inf Model 55(11):2324\u20132337. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559","journal-title":"J Chem Inf Model"},{"issue":"D1","key":"6441_CR41","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, Pon A, Cox J, Chin NEL, Strawbridge SA, Garcia-Patino M, Kruger R, Sivakumaran A, Sanford S, Doshi R, Khetarpal N, Fatokun O, Doucet D, Zubkowski A, Rayat DY, Jackson H, Harford K, Anjum A, Zakir M, Wang F, Tian S, Lee B, Liigand J, Peters H, Wang RQR, Nguyen T, So D, Sharp M, da Silva R, Gabriel C, Scantlebury J, Jasinski M, Ackerman D, Jewison T, Sajed T, Gautam V, Wishart DS (2024) DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res 52(D1):D1265-d1275. https:\/\/doi.org\/10.1093\/nar\/gkad976","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"6441_CR42","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model 61(8):3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"issue":"1","key":"6441_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0022-2836(95)80037-9","volume":"245","author":"G Jones","year":"1995","unstructured":"Jones G, Willett P, Glen RC (1995) Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol 245(1):43\u201353. https:\/\/doi.org\/10.1016\/S0022-2836(95)80037-9","journal-title":"J Mol Biol"},{"key":"6441_CR44","doi-asserted-by":"publisher","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking11Edited by Cohen FE. J Mol Biol 267(3):727\u2013748. https:\/\/doi.org\/10.1006\/jmbi.1996.0897","DOI":"10.1006\/jmbi.1996.0897"},{"issue":"10","key":"6441_CR45","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1016\/j.sjbs.2020.06.005","volume":"27","author":"AB Gurung","year":"2020","unstructured":"Gurung AB, Ali MA, Lee J, Abul Farah M, Al-Anazi KM (2020) In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors. Saudi J Biol Sci 27(10):2674\u20132682. https:\/\/doi.org\/10.1016\/j.sjbs.2020.06.005","journal-title":"Saudi J Biol Sci"},{"issue":"22","key":"6441_CR46","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1021\/acs.biochem.2c00489","volume":"61","author":"VM Sasi","year":"2022","unstructured":"Sasi VM, Ullrich S, Ton J, Fry SE, Johansen-Leete J, Payne RJ, Nitsche C, Jackson CJ (2022) Predicting antiviral resistance mutations in SARS-CoV-2 main protease with computational and experimental screening. Biochemistry 61(22):2495\u20132505. https:\/\/doi.org\/10.1021\/acs.biochem.2c00489","journal-title":"Biochemistry"},{"issue":"11","key":"6441_CR47","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1021\/acs.jcim.3c00344","volume":"63","author":"J Clayton","year":"2023","unstructured":"Clayton J, de Oliveira VM, Ibrahim MF, Sun X, Mahinthichaichan P, Shen M, Hilgenfeld R, Shen J (2023) Integrative approach to dissect the drug resistance mechanism of the H172Y mutation of SARS-CoV-2 main protease. J Chem Inf Model 63(11):3521\u20133533. https:\/\/doi.org\/10.1021\/acs.jcim.3c00344","journal-title":"J Chem Inf Model"},{"issue":"9","key":"6441_CR48","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","volume":"65","author":"Y Unoh","year":"2022","unstructured":"Unoh Y, Uehara S, Nakahara K, Nobori H, Yamatsu Y, Yamamoto S, Maruyama Y, Taoda Y, Kasamatsu K, Suto T, Kouki K, Nakahashi A, Kawashima S, Sanaki T, Toba S, Uemura K, Mizutare T, Ando S, Sasaki M, Orba Y, Sawa H, Sato A, Sato T, Kato T, Tachibana Y (2022) Discovery of S-217622, a noncovalent oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19. J Med Chem 65(9):6499\u20136512. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00117","journal-title":"J Med Chem"},{"key":"6441_CR49","doi-asserted-by":"publisher","unstructured":"Lee Jonathan T, Yang Q, Gribenko A, Perrin BS, Zhu Y, Cardin R, Liberator Paul A, Anderson Annaliesa S, Hao L (2022) Genetic surveillance of SARS-CoV-2 Mpro reveals high sequence and structural conservation prior to the introduction of protease inhibitor paxlovid. mBio 13(4):e00869\u201300822.  https:\/\/doi.org\/10.1128\/mbio.00869-22","DOI":"10.1128\/mbio.00869-22"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-025-06441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-025-06441-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-025-06441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:04:37Z","timestamp":1757311477000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-025-06441-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6441"],"URL":"https:\/\/doi.org\/10.1007\/s00894-025-06441-5","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}